| [1] |
Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality [J]. Gut, 2016, 66(4): 683-691.
|
| [2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA: A Cancer Journal for Clinicians, 2016, 66(2): 115-132.
|
| [3] |
Piepho RW. Overview of the angiotensin-converting-enzyme inhibitors [J]. Am J Health-Syst Pharm, 2000, 57(10): S3-7.
|
| [4] |
Ishimatsu S, Itakura A, Okada M, et al. Angiotensin Ⅱ augmented migration and invasion of choriocarcinoma cells involves PI3K activation through the AT1receptor [J]. Placenta, 2006, 27(6-7): 587-591.
|
| [5] |
Zhang X, Zheng J, Yan Y, et al. Angiotensin-converting enzyme 2 regulates autophagy in acute lung injury through AMPK/mTOR signaling [J]. Arch Biochem Biophys, 2019, 9(15): 672.
|
| [6] |
Yamaguchi M, Hirai S, Sumi T. Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma [J]. Biochem Biophys Res Commun, 2017, 487(3): 613-618.
|
| [7] |
Kurtipek E, Bekci TT, Kesli R, et al. The role of neutrophil lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J]. J Pak Med Assoc, 2015, 65(12): 1283-1287.
|
| [8] |
Ali FF, Ahmed AF, Elroby Ali DM. Underlying mechanisms behind the protective effect of angiotensin (1-7) in experimental rat model of ovarian ischemia reperfusion injury [J]. Life Sci, 2019, 5(235): 116840.
|
| [9] |
Zhang Q, Lu S, Li T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway [J]. J Exp Clin Cancer Res, 2019, 38(1): 173.
|
| [10] |
Yu C, Tang W, Wang Y, et al. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry. [J]. Cancer Lett, 2016, 376(2): 268-277.
|